Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • June 01 2023

    Client Alert: Call To Action: The Sweat Act Is Once Again On The Table

    The Securing Wages Enforced Against Theft (“SWEAT”) Act is starting to gain traction in the State legislature again. This harmful legislation would allow for employees who believe they are victims of wage theft to take out a personal lien on business owners, managers, and other shareholders before proving their case. If passed, we would likely see a dramatic increase in the amount of litigation in this space and this bill would severely hamper businesses from being able to operate.

    Click here to read the alert.

  • May 31 2023

    Microbot Medical Inc. announced the closing of its Registered Direct offering in the amount of $2,660,000. EG&S acted as counsel to the Placement Agent.

  • May 30 2023

    Agile Therapeutics, Inc. announced the closing of its Public Offering in the amount of $7,500,000. EG&S acted as counsel to the Placement Agent.

  • May 30 2023

    Client Alert: New York City Enacts Height and Weight Anti-Discrimination Law

    Last Friday, May 26, 2023, New York City enacted an anti-discrimination law that prohibits discrimination in employment, housing, and access to public businesses based on an individual’s height or weight. This new law will go into effect on November 22, 2023.

    Click here to read the alert.

  • May 28 2023

    Citius Pharmaceuticals, Inc. announced the closing of its Registered Direct offering in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.

  • May 25 2023

    Acurx Pharmaceuticals, Inc. announced the closing of its Registered Direct offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.

  • May 23 2023

    Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announced the pricing of its previously announced underwritten public offering. Gross proceeds from the offering are expected to be approximately $4 million. EGS acted as counsel to Maxim Group LLC, the sole book-running manager in the offering.

  • May 23 2023

    NovaBay Pharmaceuticals, Inc. announced the closing of its Private Placement offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”